Accessibility Menu
 
Exscientia logo

Exscientia

(NASDAQ) EXAI

Current PriceN/A
Market CapN/A
Since IPO (2021)-82%
5 YearN/A
1 Year-17%
1 Month-7%

Exscientia Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$17.07M

Net Income (TTM)

$150.51M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Exscientia

Industry

Biotechnology

Employees

483

CEO

David Hallett, PhD

Headquarters

Oxford, OX4 4GE, GB

EXAI Financials

Key Financial Metrics (TTM)

Gross Margin

-36%

Operating Margin

-9%

Net Income Margin

-7%

Return on Equity

-35%

Return on Capital

-39%

Return on Assets

-29%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$7.32M

Operating Income

$176.00M

EBITDA

$145.45M

Operating Cash Flow

$117.60M

Capital Expenditure

$26.66M

Free Cash Flow

$144.26M

Cash & ST Invst.

$363.05M

Total Debt

$18.92M

Exscientia Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$4.93M

-44.5%

Gross Profit

$2.60M

-221.5%

Gross Margin

-52.74%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

483

N/A

Net Income

$52.13M

-67.0%

EBITDA

$47.00M

-62.4%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Net Cash

$225.51M

-35.3%

Accounts Receivable

$49.62M

+97.3%

Inventory

$0.00

N/A

Long Term Debt

$15.40M

-3.8%

Short Term Debt

$3.17M

+37.6%

Return on Assets

-28.58%

N/A

Return on Invested Capital

-39.49%

N/A

Free Cash Flow

$44.81M

-17.4%

Operating Cash Flow

$36.78M

-7.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IKNAIkena Oncology, Inc.
$17.16+1152.55%
SAGESage Therapeutics, Inc.
$8.68+0.00%
NAGENiagen Bioscience Inc
$4.38-3.10%
RGLSRegulus Therapeutics Inc.
$8.16+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%
NOKNokia
$8.82+0.07%

Questions About EXAI

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.